Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions

Pharmaceutical interest in the human intestinal microbiota has increased considerably, because of the increasing number of studies linking the human intestinal microbial ecology to an increasing number of non-communicable diseases. Many efforts at modulating the gut microbiota have been made using p...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-03, Vol.13, p.841782-841782
Main Authors: Spisni, Enzo, Turroni, Silvia, Alvisi, Patrizia, Spigarelli, Renato, Azzinnari, Demetrio, Ayala, Dario, Imbesi, Veronica, Valerii, Maria Chiara
Format: Article
Language:English
Subjects:
bacteria
immunomodulation
microbiota
Pharmacology
postbiotic
prebiotic
probiotics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pharmaceutical interest in the human intestinal microbiota has increased considerably, because of the increasing number of studies linking the human intestinal microbial ecology to an increasing number of non-communicable diseases. Many efforts at modulating the gut microbiota have been made using probiotics, prebiotics and recently postbiotics. However, there are other, still little-explored opportunities from a pharmaceutical point of view, which appear promising to obtain modifications of the microbiota structure and functions. This review summarizes all and clinical studies demonstrating the possibility to positively modulate the intestinal microbiota by using probiotics, prebiotics, postbiotics, essential oils, fungus and officinal plants. For the future, clinical studies investigating the ability to impact the intestinal microbiota especially by using fungus, officinal and aromatic plants or their extracts are required. This knowledge could lead to effective microbiome modulations that might support the pharmacological therapy of most non-communicable diseases in a near future.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2022.841782